Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Total Liabilities: 2016-2020

Historic Total Liabilities for Monopar Therapeutics (MNPR) over the last 3 years, with Sep 2020 value amounting to $664,468.

  • Monopar Therapeutics' Total Liabilities rose 37.38% to $664,468 in Q3 2020 from the same period last year, while for Sep 2020 it was $664,468, marking a year-over-year increase of 37.38%. This contributed to the annual value of $724,165 for FY2019, which is 81.24% up from last year.
  • Latest data reveals that Monopar Therapeutics reported Total Liabilities of $664,468 as of Q3 2020, which was up 2.52% from $648,148 recorded in Q2 2020.
  • Monopar Therapeutics' 5-year Total Liabilities high stood at $724,165 for Q4 2019, and its period low was $64,510 during Q4 2016.
  • Moreover, its 3-year median value for Total Liabilities was $468,272 (2019), whereas its average is $485,212.
  • Per our database at Business Quant, Monopar Therapeutics' Total Liabilities soared by 383.44% in 2017 and then fell by 23.53% in 2020.
  • Quarterly analysis of 5 years shows Monopar Therapeutics' Total Liabilities stood at $64,510 in 2016, then surged by 383.44% to $311,867 in 2017, then climbed by 28.12% to $399,551 in 2018, then spiked by 81.24% to $724,165 in 2019, then spiked by 37.38% to $664,468 in 2020.
  • Its Total Liabilities was $664,468 in Q3 2020, compared to $648,148 in Q2 2020 and $443,520 in Q1 2020.